Latest receivables for OME: $48M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest receivables for OME is $48M as of September 2017. That compares with $47M in the prior-year period — up 1.9% year over year. Investors often review this figure alongside Omega Protein's historical trend and sector peers before judging valuation or financial health.
Over the past year, OME's receivables moved from $47M to $48M — a 1.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Omega Protein's operating scale or balance-sheet position.
A receivables figure of $48M for OME is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting OME's receivables ($48M), review year-over-year change from $47M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.